• HRT Financial LP cut its stake in Clearmind Medicine, selling 22,139 Class A shares on June 16.
• The shares were sold at USD 3.31 each.
• HRT Financial LP reported 81,353 Class A shares beneficially owned following the sale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001475597-26-000092), on June 18, 2026, and is solely responsible for the information contained therein.